ETS2 targets ZMYND11 to inhibit thyroid cancer progression via the mTOR signaling pathway
Abstract Background: Despite advancements in thyroid cancer (THCA) treatment, the prognosis for advanced cases remains poor. Cellular senescence is crucial…
Guoping Zhu
The Prognostic Value of PERK in Cancer and Its Relationship With Immune Cell Infiltration
Abstract Background: Protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK) is a type I transmembrane protein that functions as an…